On November 11, 2021, Compugen Ltd. closed the transaction. The company announced a private placement of 2,332,815 shares at a price of $8.57333 per share for gross proceeds of $19,999,992.82395. The transaction included participation from returning investor, Bristol-Myers Squibb Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.99 USD | +0.66% | -1.92% | -14.27% |
May. 01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.27% | 89.17B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Compugen Ltd. announced that it has received $19.999993 million in funding from Bristol-Myers Squibb Company